Search Everything in One Place

Explore the web, images, videos, news, and more – all in one place.

Finance

China Pharma Holdings stock is trending — CPHI soars nearly 700% on Tuesday, adds 10% after hours

A hand holds a glowing stock chart with red and green lines culminating in a bright green upward arrow.
A hand holds a glowing stock chart with red and green lines culminating in a bright green upward arrow.

China Pharma Holdings, Inc. CPHI shares are trending on Tuesday night. Shares of the pharmaceutical company jumped 9.74% to $8.89 after the bell on Tuesday. This surge in the late trading session follows an intraday rally of 694.12%, where the stock closed at $8.10, according to Benzinga Pro data. CPHI experienced an exceptionally elevated trading session on Tuesday. Volume reached 93.61 million shares, more than 21 times the stock’s average...

China Pharma Holdings, Inc. CPHI shares are trending on Tuesday night.

Shares of the pharmaceutical company jumped 9.74% to $8.89 after the bell on Tuesday.

This surge in the late trading session follows an intraday rally of 694.12%, where the stock closed at $8.10, according to Benzinga Pro data.

CPHI experienced an exceptionally elevated trading session on Tuesday. Volume reached 93.61 million shares, more than 21 times the stock’s average daily volume of 4.39 million shares.

Short interest in the stock stood at just 0.09%, suggesting the rally was not driven by a short squeeze.

Company Cites No Material Developments

The unusual trading activity prompted NYSE American to contact the company, in line with its usual practice. In response, China Pharma announced after the markets closed that it was not aware of any material corporate developments that would explain the recent market activity.

The company advised shareholders and prospective investors to exercise caution and rely only on information in its Securities and Exchange Commission filings and press releases.

Trading Metrics, Technical Analysis

China Pharma Holdings has a market capitalization of $328.23 million, a 52-week high of $19.19 and a 52-week low of $0.38.

The Relative Strength Index (RSI) of CPHI stands at 94.04.

The biotech stock has gained 357.63% over the past 12 months. In the past month alone, it has surged 1,009.59%.

CPHI is currently trading near the lower end of its 52-week range. The stock is 41.0% of the way between its 52-week low and high.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo: Ole.CNX / Shutterstock

SPONSORED

Retirement can be a difficult part of life to navigate, and a financial advisor can help. Finding a qualified financial advisor doesn't have to be hard. SmartAsset's free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you're ready to find an advisor who can help you achieve your financial goals, get started now.

This article China Pharma Holdings Stock Is Trending — CPHI Soars Nearly 700% on Tuesday, Adds 10% After Hours originally appeared on Benzinga.com.

Read full story on Benzinga

Related News

More stories you might be interested in.

Anthony Scaramucci explains why he's long Bitcoin and gold: 'Imagine an American president... sitting in front of a $55 trillion deficit'
Benzinga·1 hour ago

Anthony Scaramucci explains why he's long Bitcoin and gold: 'Imagine an American president... sitting in front of a $55 trillion deficit'

SkyBridge Capital founder Anthony Scaramucci positioned Bitcoin (CRYPTO: BTC) and gold as “part of the answer” to a changing monetary system under strain from fiscal pressures and declining purchasing power. Deficit Spending to Trigger High Inflation? Scaramucci voiced his concerns on X about the potential impact of deficit spending and inflation on the economy. The former White House Communications Director warned that national debt could rise...

Jim Cramer picks Micron, Applied Materials and Intel or AMD as top semiconductor bets after AI selloff, says Supermicro is 'great for Nvidia'
Benzinga·2 hours ago

Jim Cramer picks Micron, Applied Materials and Intel or AMD as top semiconductor bets after AI selloff, says Supermicro is 'great for Nvidia'

On Tuesday, Jim Cramer shared his latest semiconductor picks, singling out Micron Technology Inc. MU, Applied Materials Inc. AMAT and either Intel Corp. INTC or Advanced Micro Devices Inc. AMD as his top choices if investors had to own stocks across the semiconductor “food chain.” Cramer Names His Favorite Chip Stocks After Tech Pullback Taking to X, Cramer wrote, “OK, IF you have to, lets go with Micron, AMAT and Intel/AMD for the ones I like...

Bernie Sanders says critics were wrong after report reveals US-China AI talks: 'Better late than never'
Benzinga·2 hours ago

Bernie Sanders says critics were wrong after report reveals US-China AI talks: 'Better late than never'

On Tuesday, Sen. Bernie Sanders (I-Vt) argued that his earlier push for U.S.-China cooperation on artificial intelligence has been validated after reports emerged that Washington and Beijing are preparing for formal AI talks. Sanders Says US-China AI Dialogue Vindicates Earlier Position Sanders took to X and highlighted a reversal by critics who opposed his call for international AI cooperation. “3 months ago, I was told how wrong I was for...

SK Hynix dismisses Intel Ohio buyout report: 'We have no plans for an acquisition' (updated)
Benzinga·2 hours ago

SK Hynix dismisses Intel Ohio buyout report: 'We have no plans for an acquisition' (updated)

Editor’s Note: This story has been updated to include a response from an Intel spokesperson. SK hynix Inc SKHY said Tuesday it has neither pursued nor decided to acquire Intel Corp‘s INTC Ohio semiconductor campus, denying a media report that claimed the South Korean memory chipmaker was in talks to buy the site. SK hynix Responds to Korea JoongAng Daily Report SK hynix issued the clarification in a Korea Exchange filing after Korea JoongAng...

Jamie Dimon says he has seen the numbers and SpaceX’s orbital data centers ‘could actually work’ despite technical, valuation risks
Benzinga·19 hours ago

Jamie Dimon says he has seen the numbers and SpaceX’s orbital data centers ‘could actually work’ despite technical, valuation risks

JPMorgan Chase & Co. JPM CEO Jamie Dimon on Monday called Starlink an "extraordinary product" and said SpaceX’s SPCX plan to build artificial-intelligence data centers in orbit could work, offering a prominent Wall Street endorsement as the newly public company’s shares hover near their IPO price. Dimon Sees Orbital Computing’s Economic Potential Speaking on "The Master Investor Podcast with Wilfred Frost,” Dimon called SpaceX "an extraordinary...

Top